Park Ha Biological Technology is trading 8.41% up at $2.45 after the October 26, 2026 regular session, with no verified company announcement or new catalyst explaining the after-hours increase. - A class-action notice updated October 26 republishes an August 19 release about an existing lawsuit, rather than reporting a new event. - Broad indexes also rose, but available evidence does not establish that broader market sentiment caused the stock’s after-hours move.